Stocks
Novavax, Inc.NVAX
NASDAQHealthcareBiotechnology$10.23-0.63%
Price as of · delayed, not real-time
A biotechnology company focused on developing vaccines and immunotherapies, it gained significant attention for its COVID-19 vaccine candidate. Investors closely monitor its progress due to its potential in addressing global health challenges and its role in the competitive vaccine market.
Market Cap: $1.7B52W Range: $5.01 – $11.97
Congressional Interest in Novavax, Inc. (NVAX)
3 members of Congress have disclosed 4 trades in Novavax, Inc. (NVAX), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
3
Buys
1
Sells
3
Who in Congress Is Trading NVAX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-01-06 | Kurt Schrader | sell | $1K – $15K |
| 2020-10-13 | Pat Roberts | sell | $1K – $15K |
| 2020-08-17 | Pat Roberts | buy | $1K – $15K |
| 2010-01-11 | JAMES B. RENACCI | sell | $3,414.40 |